ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICHARD SEITZ MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 198

$703K Total Retail Price of All Prescriptions

Rank: 28 out of 198

556 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 14,439 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LISINOPRIL 638 571 1 6
AMLODIPINE BESYLATE 614 560 2 4
SIMVASTATIN 587 536 3 2
OMEPRAZOLE 572 507 4 3
LEVOTHYROXINE SODIUM 515 484 5 1
FUROSEMIDE 501 468 6 5
HYDROCODONE-ACETAMINOPHEN 391 288 S3 7 8
WARFARIN SODIUM 384 335 8 7
METOPROLOL SUCCINATE 361 344 9 11
ATORVASTATIN CALCIUM 354 323 10 12
CITALOPRAM HBR 349 337 11 20
ATENOLOL 346 324 12 17
METFORMIN HCL 304 273 13 13
GABAPENTIN 286 243 14 14
TRAMADOL HCL 272 238 15 15
MELOXICAM 253 211 16 30
PRAVASTATIN SODIUM 248 202 17 19
LOSARTAN POTASSIUM 231 215 18 18
METOPROLOL TARTRATE 221 198 19 10
PANTOPRAZOLE SODIUM 155 147 20 31
PREDNISONE 151 113 21 29
FENOFIBRATE 149 113 22 61
ZOLPIDEM TARTRATE 142 132 23 22
HYDROCHLOROTHIAZIDE 141 125 24 16
CRESTOR 139 123 25 26
GEMFIBROZIL 136 122 26 110
POTASSIUM CHLORIDE 132 123 27 9
FLUTICASONE PROPIONATE 129 113 28 39
GLYBURIDE 127 105 R 29 103
RISPERIDONE 122 122 30 82
CLONIDINE HCL 122 119 30 52
TRAZODONE HCL 119 94 32 50
DIGOXIN 119 98 32 43
ALENDRONATE SODIUM 116 107 34 21
RANITIDINE HCL 114 98 35 54
SPIRONOLACTONE 113 112 36 37
MIRTAZAPINE 108 108 37 44
NAMENDA 103 103 38 33
ROPINIROLE HCL 102 92 39 74
DONEPEZIL HCL 101 101 40 28
CARBIDOPA-LEVODOPA 101 101 40 71
ADVAIR DISKUS 99 88 42 47
ALLOPURINOL 99 99 42 23
ALBUTEROL SULFATE 94 78 44 113
LOSARTAN-HYDROCHLOROTHIAZIDE 93 93 45 49
GLIPIZIDE 92 79 46 62
CARVEDILOL 89 73 47 24
SERTRALINE HCL 86 86 48 25
TAMSULOSIN HCL 86 86 48 27
PAROXETINE HCL 85 68 50 65
ISOSORBIDE MONONITRATE ER 84 84 51 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 82 52 38
TIZANIDINE HCL 81 40 53 171
CIPROFLOXACIN HCL 80 76 54 55
NEXIUM 75 54 55 40
LYRICA 75 42 55 91
LANTUS 71 64 57 46
TOPIRAMATE 69 21 58 197
ENALAPRIL MALEATE 69 63 58 51
SPIRIVA 66 44 60 63
POLYETHYLENE GLYCOL 3350 62 61 61 41
PLAVIX 62 62 61 66
CYCLOBENZAPRINE HCL 61 39 R 63 67
BENAZEPRIL HCL 61 61 63 45
AZITHROMYCIN 60 52 65 56
JANUVIA 60 52 65 86
LEVOFLOXACIN 60 46 65 81
TRIAMCINOLONE ACETONIDE 60 55 65 143
VERAPAMIL ER 59 59 69 117
AMITRIPTYLINE HCL 59 37 R 69 69
LIPITOR 57 48 71 116
TORSEMIDE 57 52 71 75
OXYBUTYNIN CHLORIDE 56 56 73 89
TRIAMTERENE-HCTZ 54 38 74 32
BYSTOLIC 54 54 74 58
CLOPIDOGREL 53 53 76 42
SUCRALFATE 53 35 76 165
KLOR-CON M20 52 35 78 137
BENICAR 51 51 79 100
SYNTHROID 51 51 79 36
DOXYCYCLINE HYCLATE 50 43 81 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.